SLXN - Silexion Therapeutics | Financials | Fundamentei

12/2023

1 financial

12/2023

Year	Revenue	EBITDA	Net Inc	Net Mrg	Equity	ROE	Net Debt	ND/EBITDA	OCF SBC	Capex	FCF	Free SBC	EPS
12/2023	0	-5	-5	L	-15	L	-4	-	-5	-0	1	-5	L

To see all financials—including updated, you must be Premium.